Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

Abstract Background The incidence of colorectal cancer (CRC) is considered to be the third-highest malignant tumor among all carcinomas. The alterations in cellular bioenergetics (metabolic reprogramming) are associated with several malignant phenotypes in CRC, such as tumor cell proliferation, inva...

Full description

Bibliographic Details
Main Authors: Jiaxin Liu, Yimin Li, Qing Xiao, Yuanyuan Li, Yuqian Peng, Yaqi Gan, Guang Shu, Hanxi Yi, Gang Yin
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Cancer
Subjects:
CPT2
Colorectal cancer
Metabolism
TCGA
GEO
Online Access:https://doi.org/10.1186/s12885-022-10126-0

Internet

https://doi.org/10.1186/s12885-022-10126-0

Similar Items